Sober for Several Years, Things Are Great and Then Relapsing
Now we know how common this is, why, and strategies to prevent relapse.
Posted March 23, 2026 | Reviewed by Monica Vilhauer Ph.D.
Sometimes people are sober and in recovery from alcohol use disorder (AUD) for several years, but relapse. Why?
Alcohol use disorder is a chronic, often relapsing medical condition affecting millions worldwide. Although addiction medicine textbooks recognize AUD as a long-term disorder requiring sustained management , most studies focus on weeks or months following detoxification/treatment. This has led many to believe that if a person doesn’t relapse within months, they won’t relapse later. Sadly, this isn’t true, and some relapse even several years later. These assumptions also shape public perception, where people with AUDs are expected to return to “normal” within months, contributing to stigma when difficulties persist or relapse occurs. Harvard’s John F. Kelly and colleagues in their 2026 study address both acute relapses to alcohol abuse and the subtle, gradual processes that can occur even years after sobriety/remission.
Relapse is best understood not as a discrete event but instead as the endpoint on a slippery slope of gradual deterioration. However, importantly, the researchers did not find “all alcoholics relapse.” Instead, they demonstrated that relapse is common after treatment, especially early on. About 40–70% in recovery relapse in the first year after treatment. This also means 30-60% do not relapse. They may relapse later, and some never relapse.
Long-Term Sobriety, Then Relapse
Most traditional relapse-prevention strategies stress short-term approaches to reduce cravings, manage triggers, delay use, and build coping skills in early abstinence. While these approaches are important, they do not address relapses that occur after prolonged periods, even years of sobriety.
Little research has examined relapse after extended abstinence. Kelly and colleagues addressed this gap by examining individuals who relapsed after at least one year of remission (the average sobriety duration was 3.6 years before relapse). The results uncovered a clinical myth. This was no out-of-the-blue relapse occurring suddenly, without warning. Instead, analysis revealed that participants reported an average of 4 factors contributing to relapse, spanning multiple domains, including biological, psychological, social, and recovery-support engagement factors.
Over 80% of relapsers said decreased attention to recovery activities contributed to their relapse. These relapsers had reduced participation in self-help meetings, engaged less with recovery-support networks, and made sobriety a lower priority. Relapsers stopped paying attention to factors helping them maintain sobriety.
Relapses often happen slowly and subtly. People sober for years may become over-confident, reducing their recovery-support activities. They likely think they are “safe” and don’t need activities like AA meetings. But over time, this reduced watchfulness weakens key protective factors previously helping them sustain abstinence.
Psychological, Physical, and Social Warning Signs
Relapse rarely occurs suddenly. Instead, it tends to develop gradually through the accumulation of multiple warning signs across different areas of life. Because there are no biological relapse biomarkers , clinicians must rely on structured recovery checkup monitoring "warning sign" questions. The researchers found that biological symptoms significantly affecting abstinence in relapsers were chronic pain and engaging in recreational drug use. Early biological relapse risk warning signs also include problems with sleep, changes in energy, appetite , weight gain or loss.
The new study also found that psychological and social changes were stronger predictors of relapse than biological markers. Depression or anxiety were common preceding factors, as were greater levels of impulsivity, and lower life satisfaction. Social aspects increasing relapse risks were loneliness , isolation, more time spent around alcohol, and changes in work or housing.
Alcoholics Anonymous and Mechanisms of Recovery
Kelly and White (2010) proposed a treatment model with long-term monitoring, continuing care, recovery-support engagement, and rapid re-intervention when relapse warning signs emerge. Because relapse risks often develop gradually, routine monitoring of individuals’ psychosocial function may help clinicians prevent relapses.
A landmark Cochrane systematic review of 27 studies and 10,565 participants, led by John F. Kelly, found that manualized AA and Twelve-Step Facilitation (TSF) treatments are more effective at increasing continuous abstinence rates over 12–36 months than other treatments such as cognitive behavioral therapy (CBT). The review concluded AA/TSF should be considered an effective and cost-saving treatment option for AUD.
Other studies have shown that participation in mutual-help groups strengthens abstinence-supportive social networks, enhances coping skills, improves self-efficacy , and reduces depressive symptoms. Conversely, disengagement from these recovery-support networks is associated with increased relapse risk. Thus, diminished recovery vigilance may reflect not merely reduced motivation , but a progressive loss of protective social and behavioral structures. These mechanisms closely align with the relapse risk factors identified in the 2026 study. As individuals come to perceive themselves as “cured,” recovery vigilance may decline, leading to withdrawal from supportive networks and erosion of these protective factors, thereby increasing vulnerability to relapse over time.
Under-Utilization/Non-Recommendation of AA by Physicians
Unfortunately, many doctors fail to recommend AA and similar organizations to people with AUD. Yet current evidence strongly justifies AA referral. Inadequate physician education and training and negative attitudes/stigma toward individuals with AUDs may also get in the way. Many clinicians do not know that AA and other mutual support groups are evidence-based options complementing other treatments, including medication -assisted treatments ( MATs ) for AUDs.
This lack of awareness may explain why only about 8% of adults with AUD in the past year accessed any treatment. The intense social stigma surrounding AUD affects both clinicians and patients and may impede treatment referrals. This stigma creates a disinclination to engage with mutual support groups. Physicians could help by informing patients about such groups and providing support for Twelve-Step facilitation. AUD treatment is optimized when it includes long-term monitoring, ongoing care services, and recovery support engagement. It also calls for the patient's health care providers to be vigilant, too, so that rapid re-intervention can occur when warning signs emerge.
A recovering person who prioritized recovery meetings might begin skipping some, and then all of them, or someone who previously maintained strong social connections might start withdrawing from friends and family. Recognizing these changes early can provide an opportunity for course correction—encouraging renewed engagement with treatment, support groups, or mental-health care before relapse occurs.
We should help to maximize the chances that the person with AUD gets to five years of continuous remission when the risk of developing an alcohol disorder again becomes similar to that of the general population.
This new study builds on prior work by John F. Kelly, framing alcohol use disorder recovery as a longitudinal process supported by social networks, recovery engagement, and ongoing monitoring. Relapse is rarely abrupt; it is typically preceded by reduced focus on recovery and gradual changes in psychological state, social environment, and engagement with recovery behaviors.
Relapse risk is highest in the first 1–2 years, declines after 3–5 years, and stable remission becomes more likely after five years—though risk is not eliminated. These findings support conceptualizing AUD as a chronic condition requiring sustained management, similar to diabetes mellitus. Individuals who relapse often show progressive disengagement from the systems that once supported their sobriety, reflecting diminished recovery vigilance rather than a sudden event.
Kelly JF, Klein M, Zeng K, Manske S, Abry A. Long-term relapse: markers, mechanisms, and implications for disease management in alcohol use disorder. Front Public Health. 2026 Jan 7;13:1706192. doi: 10.3389/fpubh.2025.1706192. PMID: 41573783; PMCID: PMC12819679.
Krist AH, Bradley KA. Addressing Alcohol Use. N Engl J Med. 2025 May 1;392(17):1721-1731. doi: 10.1056/NEJMcp2402121. PMID: 40305713.
Kelly JF, Humphreys K, Ferri M. Alcoholics Anonymous and other 12-step programs for alcohol use disorder. Cochrane Database Syst Rev. 2020 Mar 11;3(3):CD012880. doi: 10.1002/14651858.CD012880.pub2. PMID: 32159228; PMCID: PMC7065341.
Kelly JF, Greene MC, Bergman BG. Recovery benefits of the "therapeutic alliance" among 12-step mutual-help organization attendees and their sponsors. Drug Alcohol Depend. 2016 May 1;162:64-71. doi: 10.1016/j.drugalcdep.2016.02.028. Epub 2016 Feb 27. PMID: 26961963; PMCID: PMC5331924.
Hoeppner BB, Williamson AC, Simpson H, DeCristofaro D, Weerts C, Riggs MJ, Futter A, Mericle AA, Rutherford PX, Hoffman LA, Rao V, McCarthy P, Ojeda J and Hoeppner SS (2025) How to measure the effectiveness of recovery community centers: insights gained from a nationwide survey of directors of RCCs. Front. Public Health 13:1532812. doi: 10.3389/fpubh.2025.1532812
Kelly JF, Westerhoff CM. Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms. Int J Drug Policy. 2010 May;21(3):202-7. doi: 10.1016/j.drugpo.2009.10.010. Epub 2009 Dec 14. PMID: 20005692.
Kelly JF, Bergman B, Hoeppner BB, Vilsaint C, White WL. Prevalence and pathways of recovery from drug and alcohol problems in the United States population: Implications for practice, research, and policy. Drug Alcohol Depend. 2017 Dec 1;181:162-169. doi: 10.1016/j.drugalcdep.2017.09.028. Epub 2017 Oct 18. PMID: 29055821; PMCID: PMC6076174.
Kelly JF, et al. A 3-year study of addiction mutual-help group participation following intensive outpatient treatment. Alcohol Clin Exp Res. 2006 Aug;30(8):1381-92. doi: 10.1111/j.1530-0277.2006.00165.x. PMID: 16899041.
Share this post Facebook Bluesky Linkedin Email
There was a problem adding your email address. Please try again.
By submitting your information you agree to the Psychology Today Terms & Conditions and Privacy Policy
Mark S. Gold, M.D., is a pioneering researcher, professor, and chairman of psychiatry at Yale, the University of Florida, and Washington University in St Louis.
Get the help you need from a therapist near you–a FREE service from Psychology Today.
This article is part of the Bringwise Psychology Journal — daily insights on human behavior, mental health, and personal growth.